Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-10 01:36 | 2026-03-05 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $48.86 | 3,627 | $177,227 | 432,881 | -0.8% |
| 2026-03-04 05:12 | 2026-03-02 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $50.16 | 17,002 | $852,848 | 436,508 | -3.7% |
| 2025-12-06 00:12 | 2025-12-03 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $100.00 | 13,000 | $1,300,000 | 368,818 | -3.4% |
| 2025-10-17 01:17 | 2025-10-15 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $78.47 | 14,979 | $1,175,393 | 381,818 | -3.8% |
| 2025-10-08 23:14 | 2025-10-06 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $62.50 | 81,385 | $5,086,563 | 396,797 | -17.0% |
| 2025-10-04 02:01 | 2025-10-02 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $64.00 | 9,692 | $620,312 | 478,182 | -2.0% |
| 2025-08-20 23:24 | 2025-08-19 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $32.02 | 4,202 | $134,548 | 487,874 | -0.9% |
| 2025-07-01 23:11 | 2025-06-30 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $52.00 | 9,692 | $503,984 | 492,076 | -1.9% |
| 2025-06-16 23:08 | 2025-06-12 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $42.30 | 9,692 | $410,019 | 501,768 | -1.9% |
| 2025-05-06 04:44 | 2025-05-02 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $33.93 | 48,213 | $1,635,867 | 511,460 | -8.6% |
| 2025-04-03 23:42 | 2025-03-11 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $31.20 | 2,109 | $65,801 | 559,673 | -0.4% |
| 2025-03-12 23:06 | 2025-03-07 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $31.20 | 2,109 | $65,801 | 559,673 | -0.4% |
| 2025-03-07 00:28 | 2025-03-05 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $41.51 | 525 | $21,793 | 561,782 | -0.1% |
| 2024-08-22 23:02 | 2024-08-21 | GRAL | GRAIL, Inc. | Ofman Joshua J. | Officer; President | Services-Medical Laboratories | SALE | $16.25 | 74,084 | $1,203,650 | 191,757 | -27.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.